163 related articles for article (PubMed ID: 33485792)
61. Imaging features of pancreatic metastases: A comparison with pancreatic ductal adenocarcinoma.
Galia M; Albano D; Picone D; Terranova MC; Agrusa A; Di Buono G; Licata A; Lo Re G; La Grutta L; Midiri M
Clin Imaging; 2018; 51():76-82. PubMed ID: 29448123
[TBL] [Abstract][Full Text] [Related]
62. Multi-institutional survey on imaging practice patterns in pancreatic ductal adenocarcinoma.
Kambadakone AR; Zaheer A; Le O; Bhosale P; Meier J; Guimaraes AR; Shah Z; Hough DM; Mannelli L; Soloff E; Friedman A; Tamm E
Abdom Radiol (NY); 2018 Feb; 43(2):245-252. PubMed ID: 29277858
[TBL] [Abstract][Full Text] [Related]
63. Small solid tumors (< or = 2 cm) of the pancreas: relative accuracy and differentiation of CT and MR imaging.
Rao SX; Zeng MS; Cheng WZ; Yao XZ; Jin DY; Ji Y
Hepatogastroenterology; 2011; 58(107-108):996-1001. PubMed ID: 21830431
[TBL] [Abstract][Full Text] [Related]
64. The Levels of Tumor Markers in Pancreatic Neuroendocrine Carcinoma and Their Values in Differentiation Between Pancreatic Neuroendocrine Carcinoma and Pancreatic Ductal Adenocarcinoma.
Zhuge X; Guo C; Chen Y; Feng L; Jia R; Zhao Y; Sun K; Wang Z; Chen X
Pancreas; 2018; 47(10):1290-1295. PubMed ID: 30308534
[TBL] [Abstract][Full Text] [Related]
65. The association between use of statin or aspirin and pancreatic ductal adenocarcinoma: A nested case-control study in a Korean nationwide cohort.
Choi JH; Lee SH; Huh G; Chun JW; You MS; Paik WH; Ryu JK; Kim YT
Cancer Med; 2019 Dec; 8(17):7419-7430. PubMed ID: 31637875
[TBL] [Abstract][Full Text] [Related]
66. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.
Distler M; Pilarsky E; Kersting S; Grützmann R
Int J Surg; 2013; 11(10):1067-72. PubMed ID: 24161419
[TBL] [Abstract][Full Text] [Related]
67. Temporality of body mass index, blood tests, comorbidities and medication use as early markers for pancreatic ductal adenocarcinoma (PDAC): a nested case-control study.
Tan PS; Garriga C; Clift A; Liao W; Patone M; Coupland C; Bashford-Rogers R; Sivakumar S; Hippisley-Cox J
Gut; 2023 Mar; 72(3):512-521. PubMed ID: 35760494
[TBL] [Abstract][Full Text] [Related]
68. New Onset of DiabetEs in aSsociation with pancreatic ductal adenocarcinoma (NODES Trial): protocol of a prospective, multicentre observational trial.
Illés D; Ivány E; Holzinger G; Kosár K; Adam MG; Kamlage B; Zsóri G; Tajti M; Svébis MM; Horváth V; Oláh I; Márta K; Váncsa S; Zádori N; Szentesi A; Czakó B; Hegyi P; Czakó L
BMJ Open; 2020 Nov; 10(11):e037267. PubMed ID: 33444177
[TBL] [Abstract][Full Text] [Related]
69. Pancreatic fatty degeneration and fibrosis as predisposing factors for the development of pancreatic ductal adenocarcinoma.
Tomita Y; Azuma K; Nonaka Y; Kamada Y; Tomoeda M; Kishida M; Tanemura M; Miyoshi E
Pancreas; 2014 Oct; 43(7):1032-41. PubMed ID: 24991971
[TBL] [Abstract][Full Text] [Related]
70. Use of ring-enhancement and focal necrosis to differentiate pancreatic adenosquamous carcinoma from pancreatic ductal adenocarcinoma on CT and MRI.
Schawkat K; Tsai LL; Jaramillo-Cardoso A; Paez SN; Moser JA; Decicco C; Singer T; Glickman J; Brook A; Manning MA; Mortele KJ
Clin Imaging; 2021 May; 73():134-138. PubMed ID: 33387918
[TBL] [Abstract][Full Text] [Related]
71. Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers.
Vasen H; Ibrahim I; Ponce CG; Slater EP; Matthäi E; Carrato A; Earl J; Robbers K; van Mil AM; Potjer T; Bonsing BA; de Vos Tot Nederveen Cappel WH; Bergman W; Wasser M; Morreau H; Klöppel G; Schicker C; Steinkamp M; Figiel J; Esposito I; Mocci E; Vazquez-Sequeiros E; Sanjuanbenito A; Muñoz-Beltran M; Montans J; Langer P; Fendrich V; Bartsch DK
J Clin Oncol; 2016 Jun; 34(17):2010-9. PubMed ID: 27114589
[TBL] [Abstract][Full Text] [Related]
72. Plasma protein biomarkers for early detection of pancreatic ductal adenocarcinoma.
Yu J; Ploner A; Kordes M; Löhr M; Nilsson M; de Maturana MEL; Estudillo L; Renz H; Carrato A; Molero X; Real FX; Malats N; Ye W
Int J Cancer; 2021 Apr; 148(8):2048-2058. PubMed ID: 33411965
[TBL] [Abstract][Full Text] [Related]
73. DeepPrognosis: Preoperative prediction of pancreatic cancer survival and surgical margin via comprehensive understanding of dynamic contrast-enhanced CT imaging and tumor-vascular contact parsing.
Yao J; Shi Y; Cao K; Lu L; Lu J; Song Q; Jin G; Xiao J; Hou Y; Zhang L
Med Image Anal; 2021 Oct; 73():102150. PubMed ID: 34303891
[TBL] [Abstract][Full Text] [Related]
74. Longitudinal association of fatty pancreas with the incidence of type-2 diabetes in lean individuals: a 6-year computed tomography-based cohort study.
Yamazaki H; Tauchi S; Wang J; Dohke M; Hanawa N; Kodama Y; Katanuma A; Saisho Y; Kamitani T; Fukuhara S; Yamamoto Y
J Gastroenterol; 2020 Jul; 55(7):712-721. PubMed ID: 32246380
[TBL] [Abstract][Full Text] [Related]
75. Value of EUS in early detection of pancreatic ductal adenocarcinomas in patients with intraductal papillary mucinous neoplasms.
Kamata K; Kitano M; Kudo M; Sakamoto H; Kadosaka K; Miyata T; Imai H; Maekawa K; Chikugo T; Kumano M; Hyodo T; Murakami T; Chiba Y; Takeyama Y
Endoscopy; 2014 Jan; 46(1):22-9. PubMed ID: 24218310
[TBL] [Abstract][Full Text] [Related]
76. Increased Incidence of Pancreatic Steatosis Detected Using Computed Tomography at Initial Diagnosis of Coronavirus Disease 2019.
Öz A; Akçalar S
Turk J Gastroenterol; 2023 Mar; 34(3):270-277. PubMed ID: 36919831
[TBL] [Abstract][Full Text] [Related]
77. PAM4 enzyme immunoassay alone and in combination with CA 19-9 for the detection of pancreatic adenocarcinoma.
Gold DV; Gaedcke J; Ghadimi BM; Goggins M; Hruban RH; Liu M; Newsome G; Goldenberg DM
Cancer; 2013 Feb; 119(3):522-8. PubMed ID: 22898932
[TBL] [Abstract][Full Text] [Related]
78. Serum fibrinogen as a diagnostic and prognostic biomarker for pancreatic ductal adenocarcinoma.
Chung KH; Lee JC; Lee J; Cho IK; Kim J; Jang W; Yoo BC; Hwang JH
Pancreatology; 2020 Oct; 20(7):1465-1471. PubMed ID: 32873483
[TBL] [Abstract][Full Text] [Related]
79. Extrapancreatic Nerve Plexus Invasion on Imaging Predicts Poor Survival After Upfront Surgery for Anatomically Resectable Pancreatic Cancer.
Sugimoto M; Kobayashi T; Kobayashi S; Takahashi S; Konishi M; Mitsunaga S; Ikeda M; Gotohda N
Pancreas; 2020; 49(5):675-682. PubMed ID: 32433406
[TBL] [Abstract][Full Text] [Related]
80. Cytopathologic diagnosis of oncocytic type intraductal papillary mucinous neoplasm: Criteria and clinical implications of accurate diagnosis.
Reid MD; Stallworth CR; Lewis MM; Akkas G; Memis B; Basturk O; Adsay V
Cancer Cytopathol; 2016 Feb; 124(2):122-34. PubMed ID: 26415076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
